{"id":1240,"date":"2024-06-05T07:44:06","date_gmt":"2024-06-05T07:44:06","guid":{"rendered":"https:\/\/neurosolve.net\/?p=1240"},"modified":"2024-06-05T07:44:49","modified_gmt":"2024-06-05T07:44:49","slug":"neurosolve-clinical-trial-has-been-successfully-registrated-also-on-clinicaltrials-gov-prs","status":"publish","type":"post","link":"https:\/\/neurosolve.net\/index.php\/2024\/06\/05\/neurosolve-clinical-trial-has-been-successfully-registrated-also-on-clinicaltrials-gov-prs\/","title":{"rendered":"NeuroSolve Clinical Trial has been successfully registrated also on ClinicalTrials.gov"},"content":{"rendered":"\n<p>After the registration of NeuroSolve Clinical Trial on PACTR (Pan African Clinical Trial Registry), we are now glad to announce that NeuroSolve\u2019s Clinical Trial has been successfully registered also on ClinicalTrial.gov. <\/p>\n\n\n\n<p>NeuroSolve is a four-year project funded by EDCTP3, and started on May 1, 2023. The African-European research consortium involves the University of Dar es Salaam (UDSM \u2013 Tanzania), Sokoine University of Agriculture (SUA \u2013 Tanzania), University of Zambia (UNZA \u2013 Zambia), Revolution Worldwide Srl \u2013 Impresa Sociale (R-EvoWW \u2013 Italy) and Universiteit Ghent (UGent \u2013 Belgium). NeuroSolve is committed to fight taeniasis\/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"992\" height=\"485\" src=\"https:\/\/neurosolve.net\/wp-content\/uploads\/2024\/04\/Screenshot-2024-04-22-112349.png\" alt=\"\" class=\"wp-image-1241\" srcset=\"https:\/\/neurosolve.net\/wp-content\/uploads\/2024\/04\/Screenshot-2024-04-22-112349.png 992w, https:\/\/neurosolve.net\/wp-content\/uploads\/2024\/04\/Screenshot-2024-04-22-112349-300x147.png 300w, https:\/\/neurosolve.net\/wp-content\/uploads\/2024\/04\/Screenshot-2024-04-22-112349-768x375.png 768w\" sizes=\"(max-width: 992px) 100vw, 992px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>After the registration of NeuroSolve Clinical Trial on PACTR (Pan African Clinical Trial Registry), we are now glad to announce that NeuroSolve\u2019s Clinical Trial has &hellip; <\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1240","post","type-post","status-publish","format-standard","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/posts\/1240"}],"collection":[{"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/comments?post=1240"}],"version-history":[{"count":3,"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/posts\/1240\/revisions"}],"predecessor-version":[{"id":1290,"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/posts\/1240\/revisions\/1290"}],"wp:attachment":[{"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/media?parent=1240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/categories?post=1240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurosolve.net\/index.php\/wp-json\/wp\/v2\/tags?post=1240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}